Product Development. Attach all requested documentation and attach additional pages as necessary. For all requirements include efforts of all Sublicensees. If not applicable, please so indicate by N/A. A. Provide the commercial name of any FDA-approved products, incorporating, using or that are Licensed Products/Licensed Methods that have first reached the market during the designated reporting Period. (This information is necessary for federal funding reporting requirements) Licensed Product (Name): Estimated Date of First Sale: FDA approval stage Contact Person Estimated Start Time Estimated End Time Estimated Budget Preclinical NDA Phase I Phase II Phase III Animal Studies Mfg./Production Facility Licensed Product (Name): Estimated Date of First Sale: Class Type: Completion Type: FDA Approval Stage Estimated Start Time Estimated End Time Estimated Budget PMA 501(k) IDE HDE Preclinical Phase I Phase II Phase III Mfg./Production Facility Licensed Product (Name): Estimated Date of First Sale: Contact Person Estimated Start Time Estimated End Time Estimated Budget Alpha Version Beta Version Commercial Version
Appears in 6 contracts
Samples: Exclusive License Agreement, Exclusive License Agreement, Exclusive License Agreement